Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-α in the fed but not in the fasted state

被引:11
|
作者
Wege, Nicole [1 ]
Schutkowski, Alexandra [1 ]
Boenn, Markus [2 ,4 ]
Bialek, Joanna [1 ]
Schlitt, Axel [3 ,5 ]
Noack, Frank [3 ]
Grosse, Ivo [2 ,6 ]
Stangl, Gabriele I. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Germany
[2] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany
[3] Univ Halle Wittenberg, Univ Clin Halle Saale, D-06120 Halle, Germany
[4] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany
[5] Paracelsus Harz Clin Bad Suderode, Quedlinburg, Germany
[6] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany
关键词
caloric intake; nuclear receptor; circadian pacemaker; PPAR-ALPHA; THERAPEUTIC TARGET; SEXUAL SELECTION; ANGIOGENESIS; INVOLVEMENT; METABOLISM; MUSCLE; CLOCK; MODEL;
D O I
10.1096/fj.14-267575
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor-alpha (PPAR alpha) plays a pivotal role in regulating metabolic response to fasting and is an inhibitor of inflammatory pathways in immune cells. It represents a therapeutic target for treatment of several diseases, mainly hyperlipidemia. To shed light on PPAR alpha expression changes in response to fasting, young healthy male and female volunteers were fed or fasted for 24 hours. Monocytes were analyzed every 2 hours to compile both profiles of mRNA and protein expression of PPAR alpha and its interactive partner, the circadian pacemaker brain and muscle aryl hydrocarbon receptor nuclear translocator like-1 (BMAL1). We found that women change their diurnal expression profiles of PPAR alpha and BMAL1 when switching from the fed to the fasted state, whereas men do not. Interestingly, the PPAR alpha and BMAL1 profiles of men and women in the fed state are different, whereas the profiles in the fasted state are virtually identical. The finding of diametrically opposite responses of male and female PPAR alpha expression in the fed state might have practical implication in human medicine as PPAR alpha activators like fibrates are used for the therapy of chronic lymphocytic leukemia, microvascular complications in diabetes, and kidney diseases.
引用
收藏
页码:2905 / 2911
页数:7
相关论文
共 50 条
  • [1] Regulation of peroxisome proliferator-activated receptor-α expression during lung inflammation
    Becker, Julien
    Delayre-Orthez, Carine
    Frossard, Nelly
    Pons, Francoise
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (02) : 324 - 330
  • [2] Regulation of Peroxisome Proliferator-Activated Receptor-α by MDM2
    Gopinathan, Lakshmi
    Hannon, Daniel B.
    Peters, Jeffrey M.
    Heuvel, John P. Vanden
    TOXICOLOGICAL SCIENCES, 2009, 108 (01) : 48 - 58
  • [3] Peroxisome Proliferator-Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract
    Guo, Yue-Xin
    Wang, Bo-Ya
    Gao, Han
    Hua, Rong-Xuan
    Gao, Lei
    He, Cheng-Wei
    Wang, Ying
    Xu, Jing-Dong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [4] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Wang, Lin
    Cai, Yin
    Jian, Liguo
    Cheung, Chi Wai
    Zhang, Liangqing
    Xia, Zhengyuan
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [5] Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
    Peters, Jeffrey M.
    Walter, Vonn
    Patterson, Andrew D.
    Gonzalez, Frank J.
    NPJ PRECISION ONCOLOGY, 2019, 3 (1)
  • [6] Peroxisome Proliferator-Activated Receptor-δ as Emerging Target in Liver Disease
    Schnabl, Bernd
    DRUG DEVELOPMENT RESEARCH, 2010, 71 (02) : 106 - 111
  • [7] Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α
    Lee, Ji Hae
    Jun, Hee-jin
    Hoang, Minh-Hien
    Jia, Yaoyao
    Han, Xiang Hua
    Lee, Dong-Ho
    Lee, Hak-Ju
    Hwang, Bang Yeon
    Lee, Sung-Joon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 568 - 572
  • [8] Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis
    Giaginis, Costas
    Margeli, Alexandra
    Theocharis, Stamatios
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1561 - 1572
  • [9] Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice
    Takei, Kenta
    Han, Song-iee
    Murayama, Yuki
    Satoh, Aoi
    Oikawa, Fusaka
    Ohno, Hiroshi
    Osaki, Yoshinori
    Matsuzaka, Takashi
    Sekiya, Motohiro
    Iwasaki, Hitoshi
    Yatoh, Shigeru
    Yahagi, Naoya
    Suzuki, Hiroaki
    Yamada, Nobuhiro
    Nakagawa, Yoshimi
    Shimano, Hitoshi
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 446 - 452
  • [10] Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α Activators
    Duncan, Jennifer G.
    Bharadwaj, Kalyani G.
    Fong, Juliet L.
    Mitra, Riddhi
    Sambandam, Nandakumar
    Courtois, Michael R.
    Lavine, Kory J.
    Goldberg, Ira J.
    Kelly, Daniel P.
    CIRCULATION, 2010, 121 (03) : 426 - 435